Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Culturally-Sensitive and Patient-Centered Feedback for Alzheimer's Dementia Risk Disclosure

NCT04309500 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT04309500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04309500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Culturally-Sensitive and Patient-Centered Feedback for Alzheimer's Dementia Risk Disclosure
Lead sponsor
University of Michigan
Phase
Not applicable
Overall status
Completed
Start date
May 20, 2021
Completion date
January 31, 2022
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy aging, mild cognitive impairment